Abstract. This study characterizes effects of nerve growth factor (NGF) on the steady-state level and phosphorylation of a high molecular mass microtubuleassociated protein in PC12 rat pheochromocytoma cells. Past work showed that NGF significantly raises the relative levels of this phosphoprotein, designated MAP1.2, with a time course similar to that of neurite outgrowth. To study this in greater detail, MAP1.2 in PC12 cell lysates was resolved by SDS-PAGE in gels containing 3.25% acrylamide/4 M urea and identified by comigration with material immunoprecipitated from the lysates by MAP1 antibodies. Quantification by metabolic radiolabeling with pS]methionine or by silver staining revealed a 3.0-3.5-fold increase in MAP1.2 levels relative to total cell protein after NGF treatment for 2 wk or longer. A partial increase was detectable after 3 d, but not after 2 h of NGF exposure. As measured by incorporation of [32p]phosphate, NGF had a dual effect on MAP1.2. Within 15 min to 2 h, NGF enhanced the incorporation of phosphate into MAP1.2 by two-to threefold relative to total cell phosphoproteins. This value slowly increased thereafter so that by 2 wk or more of NGF exposure, the average enhancement of phosphate incorporation per MAP1.2 molecule was over fourfold. The rapid action of NGF on MAP1.2 could not be mimicked by either epidermal growth factor, a permeant cAMP derivative, phorbol ester, or elevated K +, each of which alters phosphorylation of other PC12 cell proteins. SDS-PAGE revealed multiple forms of MAP1.2 which, based on the effects of alkaline phosphatase on their electrophoretic mobilities, differ, at least in part, in extent of phosphorylation. Before NGF treatment, most PC12 cell MAP1.2 is in more rapidly migrating, relatively poorly phosphorylated forms. After longterm NGF exposure, most is in more slowly migrating, more highly phosphorylated forms. The effects of NGF on the rapid phosphorylation of MAP1.2 and on the long-term large increase in highly phosphorylated MAP1.2 forms could play major functional roles in NGF-mediated neuronal differentiation. Such roles may include effects on microtubule assembly, stability, and cross-linking and, possibly for the rapid effects, nuclear signaling.
T HE most prominent characteristic of neuronal differentiation is the elaboration of extensive axonal and dendritic arbors. These structures are densely packed with microtubules which are required for the growth of neurites (9, 36) . The biological rules governing the initiation and extension of these structures are not fully understood but are likely to involve accessory molecules known as microtubule-associated proteins (MAPs) ~ (for review see reference 28). Among these is the high molecular mass species, MAP1, the levels of which are developmentally up regulated in mammalian brain (2, 29) . Although the distribution of MAP1 in the nervous system is widespread (5), recent immunological evidence (4) suggests that a MAP1 subspecies, MAP1B, may be more abundant than MAP1A in axons. At least in vitro, MAP1 promotes the assembly of microtubules (18) and forms filamentous arms on their surfaces (34) . In addition, stabilization of microtubules and cross-linking of microtubules to one another or to other elements of the cytoskeleton are also among the possible functional roles of MAP1.
The role of MAPs in process outgrowth by intact neuronal cells has recently been studied using a model system, the PC12 clonal line of rat pheochromocytoma cells. In the presence of nerve growth factor (NGF), these cells acquire a neuronal phenotype (13) and they may therefore be used to correlate changes in composition with the onset and elongation of neurites. In particular, NGF has been found to greatly increase the relative levels of a phosphoprotein that is recognized by antisera prepared against high molecular mass brain MAPs, associates with microtubules, comigrates with a subspecies of rat brain MAP1 by SDS-PAGE analysis, and like MAP1, but unlike MAP2, precipitates upon boiling (15) . It was unclear whether the influence of NGF on this species, designated MAP1.2 (15) , is due either to an increase in the levels of this protein, to an enhancement of its phosphorylation, or to a combination of both of these effects. Subsequently, Drubin et al. (10) used a mAb in an attempt to quantify PC12 cell MAP1 and came to the conclusion that NGF induces an increase in the levels of this protein by ~20-fold. On the other hand, Lewis et al. (22) examined MAP1 mRNA levels in PC12 cells by means of a specific cDNA probe, and noted that NGF brought about at most only a severalfold relative increase in this message.
In view of the large NGF-induced increase in phosphorylated MAP1.2 levels and of the relatively modest effect of the factor on MAP1 mRNA, we have directly reexamined the actions of NGF on the steady-state levels and the extent of phosphorylation of this protein. This type of information will be important in understanding the relative roles of MAP1 synthesis and posttranslational modification in NGFpromoted acquisition and maintenance of neuronal morphology. Our results indicate that NGF brings about a rapid (minutes), specific increase in the incorporation of phosphate into PC12 cell MAP1.2, as well as a more slowly developing (days) increase in both the extent of phosphorYlation and the relative levels of this protein. We also detect multiple forms of MAP1.2 that differ, at least in part, in degree of phosphorylation. The net long-term action of NGF, by virtue of its effects on MAP1.2 levels and phosphorylation, is to greatly enhance the cellular content of highly phosphorylated forms of MAP1.2.
Materials and Methods

Reagents
NGF was prepared from mouse salivary glands (Bio-Trol, Inc., Indianapolis, IN) by the procedure of Mobley et al. (26) . Epidermal growth factor (EGF) was a gift from Dr. Fred Maxfield, Department of Pharmacology, NYU Medical Center, New York. Alkaline phosphatases from Escherichia coli or from bovine intestinal mucosa were purchased from Sigma Chemical Co., St. Louis, MO. 8(4-Chlorophenylthio)-cyclic-adenosine-3':5' monophosphate was from Boehringer Mannheim Biochemicals, Indianapolis, IN and 12-0-tetradecanoyl-phorbol-13-acetate from Calbiochem-Behring Corp., La Jolla, CA. Pyrophosphate tetrasodium and the protease inhibitorspepstatin A, leupeptin, benzamidine, phenylmethylsulfonyl fluoride (PMSF), and trasylol-were all from Sigma Chemical Co. Reagents used for dectrophoresis were obtained from either Sigma Chemical Co. or Bio-Rad Laboratories, Richmond, CA and Tris buffers from Sigma Chemical Co.
Protein determinations by the method of Bradford (6) were carried out with reagents supplied by Bio-Rad Laboratories, using BSA (fraction V; Sigma Chemical Co.) as the standard.
Antibody Preparations
A rabbit polyclonal antiserum, 3d2, was raised against a gel-purified fusion protein consisting of a portion of the E. coli trpE protein fused to a protein encoded by a partial mouse MAPl cDNA clone (clone D, Figs. 2 and 3 in reference 22). This antiserum was shown to be specific for MAPI.2 on Western blots of purified mouse brain microtubules (Lewis, S. A., and N. J. Cowan, unpublished observation). Clone D detects an mRNA species of ,~10 kb in PC12 cells and in rat brain (22) . In addition, three previously described anti-MAP antibodies were used: a rabbit anti-bovine MAPI polyclonal antiserum (23); a rabbit anti-bovine MAP polyclonal antiserum (32) provided by Dr. P. Sherline, Division of Endocrinology, Cornell Medical College, New York, NY; and a mouse monoclonal MAP1 antibody (10) provided by Dr. D. Asai, Dept. of Biological Sciences, Purdue University, Lafayette, IN.
Cell Culture and Radiolabeling of Proteins
PCI2 cells were cultured with or without NGF as previously described (13) . NGF-treated cells were maintained in 1% donor horse serum to maximize the density of neurite outgrowth with a minimum of cell clumping (see references 1 and 3). Several experiments performed on a substrate (matrigel; Collaborative Research, Inc., Waltham, MA) that minimizes cell clumping even further gave results simlar to those carried out on air-dried collagen.
Experiments requiring comparisons among cultures subjected to different experimental treatments were executed using sister cultures of cells plated and harvested in parallel. Metabolic radiolabeling of proteins was carried out using either 50 I.tCi of [35S]methionine (1,000-1,200 Ci/mmol) in 1 ml of complete culture medium for 3 d, or 20-100 ~Ci/ml of [32PJor-thophosphate in a modified Krebs-Ringer solution (15) for 1.5-2 h. Both isotopes were purchased from New England Nuclear, Boston, MA. For NGFtreated cultures, NGF was also continuously present during exposure to the isotopes.
Immunoprecipitation and Immunoblotting of MAP1.2
For immunoprecipitations, cells were solubilized in a detergent-containing buffer (1) and then incubated with one of two different MAPI antisera-3d2 (see above) or an anti-MAP1 polyclonal serum (23) . Antigen-antibody complexes were then precipitated with protein A-Sepharose beads (Pharmacia Fine Chemicals, Piscataway, N J), solubilized in SDS sample buffer (15) , and subjected to electrophoresis on a one-dimensional slab gel as described below. Immunoprecipitated MAPI.2 was then located on the gel either by silver staining, or, when cellular proteins had been metabolically radiolabeled, by autoradiography. Immunoblotting was carried out by the method of Wiche et al. (35) .
Phosphatase Experiments
Cells were rinsed while still attached to culture dishes three times with warm (37~C) PBS (11) and then harvested at 4°C in 100 mM Tris-HCI buffer (pH 8.2) containing 1-3 mM MgC12, 2 mM PMSF, 100 klU/ml trasylol, 10 I.tg/ml leupeptin, 10 p.g/ml pepstatin A, and 10 I.tM benzamidine. The suspension was homogenized with 20 strokes in a hand-held teflon glass mortar and pestle and allowed to stand on ice for 10 rain. The supernatnat (produced by centrifugation in an Eppendorf microfuge for 10 min) was then aliquoted into tubes containing either diluent only, 10 U/ml E. coil alkaline phosphatase, or 5 or 10 I.tg/ml calf intestine alkaline phosphatase. Some tubes also contained 15-20 mM pyrophosphate tetrasodium. Incubation times were varied from 1-18 h at 35°C or 6-18 h at room temperature. The protocol which proved optimal for detection of the shift in MAPI.2 mobility by SDS-PAGE used the calf enzyme, 10 mg)inl, at room temperature for 18 h.
At the end of the incubation period, a fourfold concentrate of SDS sample buffer was added (1:3) to each reaction tube, mixed, and heated in a boiling water bath for 5 min. After separation by SDS-PAGE, proteins in the fixed gel were silver stained.
with a scanning densitometer (model GS 300; Hoefer Scientific Instruments, San Francisco, CA). The electrical output from each scan was analyzed by a PC-operated software program (Macmillan Software Co., New York, NY) modified by Steven Drexler (Department of Pharmacology, NYU Medical Center) to perform plotting and integration of protein bands. The integrated values from autoradiograms of MAP1.2 fell within the linear range of the film's reciprocity as judged by a standard curve encompassing the 20-fold dilution of a 32p-labeled source. A gel loaded with serial dilutions of a whole cell protein lysate was used to standardize the relationship between the density of the silver-stained MAP1.2 band and the amount of protein present. A linear association was found over a range of ,'~7.5-fold. Quantitative comparisons of control vs. NGF-treated cells were performed only with samples within this range.
Results
Identification and Detection of MAPI.2 in PC12 Cells
PC12 cells express a MAP1 subspecies designated MAP1.2 05). Initial experiments to compare relative MAP1.2 protein levels in control (nontreated) and long-term NGF-treated PC12 cultures were performed by radioimmunoblotting analysis (Fig. l) . Four different antibody preparations were used (see Materials and Methods), two of which were monospecific for MAP1.2 and two of which were not. Three of the antibody preparations recognized MAP1.2 in both control and NGF-treated cultures and, when used on equal aliquots of the same PC12 lysates, indicated specific increases in MAP1.2 levels ranging from 2.1-to 3.3-fold in the NGFtreated cultures (Fig. 1, A-C) . However, the fourth preparation ( Fig. 1 D) , a mAb, did not detect MAP1.2 in lysates of control cells, consequently indicating a much larger stimulation of levels by NGE Because of the variation in results with the antisera, we chose to quantify the relative levels of MAP1.2 present under different experimental conditions by direct electrophoretic comparison of whole cell lysates. To reliably resolve this high molecular mass protein, we used electrophoresis in low percentage polyacrylamide gels containing urea. Identification was confirmed by comigration with material specifically immunoprecipitated from the cells by MAP1 antibodies (Fig.  2) . To verify that the band identified as MAP1.2 does not contain significant amounts of other proteins, cell extracts (labeled and unlabeled) were subjected to immunoprecipitation with excess 3d2 antiserum. This antiserum is monospecific for MAP1.2 ( Fig. 1 ) and was prepared against fusion protein containing a sequence encoded by a partial mouse cDNA clone for MAP1 (see Materials and Methods). PAGE analysis of the protein remaining after immunoprecipitation of the control lysates revealed, both by silver staining and by fluorography of 35S-labeled material, that at least 85% of the MAP1.2 band was cleared. In addition, the 32p-labeled phosphoprotein identified as MAP1.2 in long-term NGFtreated cells was found to be 90% cleared by the antiserum. as in material detected by silver staining (Fig. 3) or immunoblotting (Fig. 1, A-C) .
Time Course and Quantification of the NGF-induced Effects on MAPI.2
Past experiments (3, 10, 15) as well as those shown in Figs. 2 and 4 reveal a long-term NGF-dependent increase in the relative levels of phosphate-labeled MAP1.2 in PC12 cells. This might result from either an increase in the steady-state level of the protein or an increased incorporation of phosphate or both. We therefore determined the contribution of each of these parameters by labeling sister cultures either with [32p]orthophosphate (for 1-3 h to measure relative phosphate incorporation) or with [35S]methionine (for 3 d to quantify steady-state protein levels). Exposure to NGF was varied from 0, 15 min, 2 h, 3 d, to 2 wk or more. Whole cell lysates were prepared from each culture, equal amounts of TCA-precipitable radioactivity subjected to SDS-PAGE, and the resolved proteins visualized by autoradiography (Fig. 4) . The autoradiographs were then scanned den- sitometrically to quantify the relative levels of radioactivity incorporated into MAP1.2.
The values obtained from multiple experiments of the type described above are summarized in Table I . An increase in the relative steady-state level of MAP1.2 protein was detectable after 3 d, but not after 2 h, of NGF exposure. In longterm NGF-treated (>2 wk) cultures, this measurement averaged 3.5-fold that in control cultures. The magnitude of this relative increase was similar to that determined by scanning densitometry of silver-stained gels, or photographic negatives thereof, containing material from control and long-term NGF-treated cells. Four independent silver-stain experiments gave the following results: 3.3 and 5.0 for directly scanned gels, and 1.9 and 2.4 for the photographic negatives. The mean value was 3.1 + 0.6 (SEM). The relative levels of MAP1.2 protein did not appear to increase further beyond 2 wk of NGF treatment.
The increase in phosphorylation of MAP1.2, in contrast, commenced within 15 min of NGF exposure. Phosphorylation of this species continued to increase further throughout the time course studied. In agreement with previous studies (3, 15) , the relative incorporation of phosphate into MAP1.2 increased by an average of 16-fold after >2 wk of NGF treatment. Table I also shows the ratios of 32p/35S incorporation into MAP1.2 after various times of exposure to NGE This provides an estimate of the relative average phosphate incorporation per molecule. After 2 h of NGF treatment, during which there was no detectable change in MAP1.2 protein levels, there was a threefold enhancement of relative phosphate incorporation into this species. In long-term NGF-treated cultures, normalization to the increase in MAPI.2 protein revealed an average enhancement of incorporation per molecule of over fourfold. These data thus show a rapid effect of NGF on MAP1.2 phosphorylation and that the large increase in phosphorylated MAP1.2 levels that occurs after long-term NGF treatment is due both to increased levels of MAP1.2 protein and to an enhanced average incorporation of phosphate per molecule.
The observed effects of NGF on MAP1.2 phosphorylation could arise from either enhanced phosphate turnover or increased steady-state phosphorylation. To distinguish between these possibilities, cultures were either exposed to long-term exposures to NGF, phosphorylation was similarly enhanced (as compared to controls) irrespective of whether labeling with phosphate was for 2 h or 3 d. These findings indicate that the observed changes were in steady-state phosphorylation and that this state is reached within 2 h. 
Role of Phosphorylation in the NGF-dependent Mobility Shift of MAP1.2
One possible contribution to the NGF-promoted shift of MAP1.2 to a more slowly migrating position by SDS-PAGE analysis is elevated phosphorylation. If this is the case, then removal of phosphate groups should increase the electrophoretic mobility of MAP1.2 in NGF-treated cell material. As illustrated in Figs. 5 and 6 A, incubation of extracts from NGF-treated cells with alkaline phosphatase converted the MAP1.2 to a form with electrophoretic mobility characteristic of that in nontreated control cells. Similar treatment of extracts from nontreated control cells also affected MAP1.2 so that it ran as a sharper band at the position of the front of the typically broad MAPI.2 band present in controls (Figs. 5 and 6 B) . Prelabeling of cells with [nP]orthophosphate confirmed the loss of phosphate during enzymatic treatment. Pyrophosphate, an inhibitor of alkaline phosphatase (27) , blocked these effects of enzymatic treatment. This indicates that the enzyme-induced shift was due to changes in phosphorylation rather than to proteolysis by a contaminant in the preparation.
Activators of Known Protein Kinases Do Not Mimic the NGF-mediated Rapid Increase in MAP1.2 Phosphorylation
Agents known to promote phosphorylation reactions via activation of known protein kinases were added to PC12 cultures during metabolic radiolabeling with [nP]orthophosphate to better understand the mechanism through which NGF acts to enhance the phosphorylation of MAPI.2.8-(4-Chlorophenylthio)-cyclic adenosine monophosphate, a permeant analog of cAMP and activator of protein kinase A (25); 12-O-tetradecanoyl-phorbol-13-acetate, which activates protein kinase C (8); or 44 mM KCI, which leads to activation of Ca++-dependent protein kinases via the opening of voltage-dependent Ca ++ channels, were used. Each of these treatments rapidly produces elevated phosphorylation of at least several PCI2 cell proteins (15, 16, 20, 24) . This was confirmed during our studies in which these treatments lead to enhanced phosphorylation of at least one other cytoskeletal protein in both NGF-treated and non-NGF-treated cultures (Aletta, J. M., and L. A. Greene, unpublished observations). It is noteworthy, however, that these agents do not promote neurite outgrowth in PC12 cell cultures. EGF was also tested. This trophic polypeptide produces several effects on PCI2 cells similar to NGF, but not neurite outgrowth (17) . EGF also triggers several rapid changes in PC12 cell protein phosphorylation (16) .
As shown in Fig. 7 , none of the above treatments mimicked the rapid effect of NGF on MAP1.2 phosphorylation. In addition, the phosphorylation of MAP1.2 in cultures exposed to NGF for 2 wk or more was not enhanced further by 2 h of treatment with any of these agents (data not shown).
Discussion
Recognition of MAP1.2 on Low Percentage Polyacrylamide/Urea Gels
We have identified the high molecular mass protein, MAP1.2, in PC12 cells before and after NGF treatment and quantified both its levels and phosphorylation. Our analysis has relied on the mobility of the protein in one-dimensional gels. The possibility that significant quantities of other proteins of equivalent electrophoretic mobility are present in the gels seems remote for several reasons. First, after immunoprecipitation with a specific antibody, only a small amount of protein of electrophoretic mobility similar to MAPI.2 remains in the lysates of both control and NGF-treated cells (see Results). In addition, in response to long-term exposure to NGF, there is a shift in the mobility of MAP1.2 (by all methods of detection) such that little protein remains at the location in the gel corresponding to the position of MAP1.2 from untreated cells. This mobility shift can be reversed by phosphatase treatment. Finally, our immunoblotting results, with the exception of that in Fig. 1 D, corroborate our quantitative data based on scanning densitometry (cf. Fig. l) .
NGF-specific Phosphorylation of MAP1.2
Previous observations have revealed that NGF produces a striking long-term increase in the relative incorporation of phosphate into PCI2 cell MAP1.2 (3, 10, 15) . We show here that this is in part due to a dual effect on phosphorylation. There is a rapid effect of NGF on phosphate incorporation into this protein followed by a slower increase in this parameter. We have estimated that by two wk or more of treatment, the average NGF-induced increase in phosphate groups is about fourfold per molecule. Our data indicate that this reflects changes in steady-state levels rather than turnover.
Our results indicate that the rapid enhancement of phosphorylation is NGF specific and cannot be reproduced by EGF or a variety of agents that lead to activation of several well-characterized protein kinases. EGF, insulin, and cAMP derivatives have also been shown to be unable to mimic the long-term effect of NGF on MAP1.2 (15) . Each of the agents used, in contrast, stimulates phosphorylation changes of other PC12 cell proteins (16, 20, 24) . This suggests that the NGF-enhanced phosphorylation of MAPI.2 is mediated either via a novel protein kinase or via inactivation of a rather specific phosphoprotein phosphatase.
The present findings may be compared with those concerning other microtubule elements. With long-term NGF treatment of PC12 cells, beta-tubulin and chartin MAPs also undergo enhanced phosphorylation (1, 3, 7) . In the latter case, this is due to a large increase in the levels of more highly phosphorylated isoforms (3). Phosphorylation of chartin MAPs is rapidly inhibited by application of Li ÷ (7), activators of adenylate cyclase (14) , or agents that lead to microtubule disassembly (1). In contrast, the phosphorylations of MAP1.2 and beta-tubulin are not significantly affected by such treatments.
Multiple Forms of MAP1.2 in PC12 Cells
The resolution of high molecular mass proteins provided by the low percentage acrylamide/4 M urea gels used here has revealed multiple forms of PC12 cell MAP1.2 with slight, but consistently detectable, differences in mobility. As indicated by our experiments with alkaline phosphatase, these differences are due, at least in part, to phosphorylation, with the least phosphorylated forms having the greatest mobility.
Our study also revealed that treatment with NGF brings about a shift in the proportion of MAP1.2 that migrates with slower electrophoretic mobility. This is consistent both with the influence of phosphorylation on the mobility of MAPI.2 in gels and with the effect of NGF on MAP1.2 phosphorylation. The observation that most of the MAP1.2 protein (as revealed by immunoblotting, silver staining, and by labeling with [35S]methionine) undergoes this shift in long-term, NGF-treated cultures is consistent with the finding that NGF increases the average number of phosphates per molecule, rather than merely increasing phosphate turnover. This also appears to be the case with short-term NGF exposure; the MAP1.2 detected by phosphate label in such cases showed a shift to lower mobility.
Although we are presently unable to reliably estimate the proportions of the various forms of MAP1.2, it is clear that very little of the MAP1.2 in non-NGF-treated PC12 cultures is in the most slowly migrating, highly phosphorylated form and, as noted above, that in contrast, this form is the most prominent in long-term, NGF-treated cultures. Thus, while the tong-term effects of NGF on overall MAP1.2 levels and phosphorylation are each reasonably modest, it is important to note that the factor appears to bring about very substantial changes in the levels of individual forms of this protein.
A presently unresolved issue is the effect of NGF treatment on the distribution of the multiple forms of MAP1.2 at early times. That is, by phosphate label, the short-term effect of NGF is to enhance phosphorylation of MAP1.2 and to retard its electrophoretic mobility, whereas, in contrast, by methionine label, little or no mobility shift is seen (cf. Fig. 4 ) under such conditions. One interpretation of these data is that at short times of treatment, NGF brings about a very large increase in phosphate incorporation into a relatively small pool of MAP1. Thus, it may be that the early action of NGF is directed at a subfraction of MAP1.2 while the long-term actions affect most of the cellular content of this protein. As noted below, this could be relevant to different functional roles of the highly phosphorylated forms. (Fig. 1 D) . In addition to such a possible structural role for the longterm effects of NGF on MAP1.2, based on its rapidity and NGF selectivity, the early increase in MAP1.2 phosphorylation could conceivably serve a signaling function. Interestingly, in this regard, a phosphorylated MAPl-like molecule has been localized at putative sites of mRNA maturation within the nuclei of fibroblasts (31). In such cells, the phosphoprotein appears in nuclei after growth stimulation. In PC12 cells, along with its promotion of neuronal differentiation, NGF regulates the expression of a variety of genes (21). Perhaps, a phosphorylated form of MAP1.2 in PC12 cell nuclei serves some function during the NGF-mediated regulation of gene expression. In agreement with this proposition, fibroblast growth factor, the only other known agent to mimic NGF's pattern of gene regulation (21) , also elicits the rapid phosphorylation of MAP1.2 (Rydel, R. E., and L. A. Greene, unpublished observations). It may also be relevant in this regard that some experimental evidence has been obtained that another cytoskeletal protein, actin, may function as an initiation factor within the nucleus (12) .
Regulation of MAP1.2 Protein Levels by NGF
